Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00259350Phase 4Completed
Phase 4, randomised, open-label trial of chlorhexidine, benzalkonium chloride, benzyl alcohol and povidone-iodine in catheter infection (2 arms), sponsored by CHU de Poitiers. Primary endpoint: Prevention of catheter colonization. Started May 2004; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00259350.